2-(n,n-dimethylamino)-6,7-dihydroxytetralin has been researched along with propranolol in 1 studies
Studies (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Trials (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Recent Studies (post-2010) (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Studies (propranolol) | Trials (propranolol) | Recent Studies (post-2010) (propranolol) |
---|---|---|---|---|---|
46 | 0 | 0 | 33,310 | 3,406 | 3,218 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rajanayagam, S; Rand, MJ; Story, DF; Xiao, XH | 1 |
1 other study(ies) available for 2-(n,n-dimethylamino)-6,7-dihydroxytetralin and propranolol
Article | Year |
---|---|
Does suppression of responsiveness to beta-adrenoceptor activation explain the enhancement of vasoconstrictor responses by alpha 2-adrenoceptor agonists?
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Phenylephrine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Tetrahydronaphthalenes; Vasoconstrictor Agents | 1989 |